Terms: = Skin cancer AND CD79B, ENSG00000007312, 974, P40259, IGB, B29 AND Treatment
16 results:
1. Sinonasal DLBCL: molecular profiling identifies subtypes with distinctive prognosis and targetable genetic features.
Eriksen PRG; de Groot F; Clasen-Linde E; de Nully Brown P; de Groen R; Melchior LC; Maier AD; Minderman M; Vermaat JSP; von Buchwald C; Pals ST; Heegaard S
Blood Adv; 2024 Apr; 8(8):1946-1957. PubMed ID: 38324724
[TBL] [Abstract] [Full Text] [Related]
2. Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study.
Weber JS; Carlino MS; Khattak A; Meniawy T; Ansstas G; Taylor MH; Kim KB; McKean M; Long GV; Sullivan RJ; Faries M; Tran TT; Cowey CL; Pecora A; Shaheen M; Segar J; Medina T; Atkinson V; Gibney GT; Luke JJ; Thomas S; Buchbinder EI; Healy JA; Huang M; Morrissey M; Feldman I; Sehgal V; Robert-Tissot C; Hou P; Zhu L; Brown M; Aanur P; Meehan RS; Zaks T
Lancet; 2024 Feb; 403(10427):632-644. PubMed ID: 38246194
[TBL] [Abstract] [Full Text] [Related]
3. Smoking is associated with infection risk in healthy blood donors.
Kjerulff B; Kaspersen KA; Dinh KM; Boldsen J; Mikkelsen S; Erikstrup LT; Sørensen E; Nielsen KR; Bruun MT; Hjalgrim H; Pedersen OB; Thørner LW; Ullum H; Ostrowski SR; Rostgaard K; Pedersen CB; Sigsgaard T; Erikstrup C
Clin Microbiol Infect; 2023 Apr; 29(4):506-514. PubMed ID: 36404421
[TBL] [Abstract] [Full Text] [Related]
4. Introducing the 'Benign Eyelid Lesion Pathway': 1 year experience of synchronous tele-oculoplastics in a tertiary hospital.
Ah-Kye L; Butt A; Gupta A; Timlin H; Daniel C; Uddin J; Thomas PBM; Sim DA; Ezra DG; Kang S
Eye (Lond); 2023 May; 37(7):1458-1463. PubMed ID: 35788698
[TBL] [Abstract] [Full Text] [Related]
5. Adjuvant treatment for melanoma in clinical practice - Trial versus reality.
de Meza MM; Ismail RK; Rauwerdink D; van Not OJ; van Breeschoten J; Blokx WAM; de Boer A; van Dartel M; Hilarius DL; Ellebaek E; Bonenkamp HJ; Blank CU; Aarts MJB; van Akkooi ACJ; van den Berkmortel FWPJ; Boers-Sonderen MJ; de Groot JWB; Haanen JB; Hospers GAP; Kapiteijn EW; Piersma D; van Rijn RS; van der Veldt AAM; Vreugdenhil A; Westgeest HM; van den Eertwegh AJM; Suijkerbuijk KPM; Wouters MWJM
Eur J Cancer; 2021 Nov; 158():234-245. PubMed ID: 34600790
[TBL] [Abstract] [Full Text] [Related]
6. Concurrent Chemoradiation Therapy With or Without Nimotuzumab in Locally Advanced Squamous Cell Lung cancer: A Phase 2 Randomized Trial.
Qiu B; Wang D; Li Q; Wu Y; Guo S; Jiang X; Fang J; Guo J; Liu F; Chu C; Wang B; Chen L; Zhang J; Liu Y; Hu Y; Liu H
Int J Radiat Oncol Biol Phys; 2021 Nov; 111(4):917-925. PubMed ID: 34229051
[TBL] [Abstract] [Full Text] [Related]
7. Elafin as a Predictive Biomarker of Acute skin Graft-
Solán L; Carbonell D; Muñiz P; Dorado N; Landete E; Chicano-Lavilla M; Anguita J; Gayoso J; Kwon M; Díez-Martín JL; Martínez-Laperche C; Buño I
Front Immunol; 2021; 12():516078. PubMed ID: 33679728
[TBL] [Abstract] [Full Text] [Related]
8. Predictors of hematologic malignancy relapse in patients with advanced chronic graft-versus-host disease.
Ruben CL; Pirsl F; Steinberg SM; Holtzman NG; Parsons-Wandell L; Baruffaldi J; Curtis LM; Mitchell SA; Kerep AZ; Cowen EW; Berger A; Joe GO; Datiles MB; Mays JW; Pavletic SZ
Bone Marrow Transplant; 2021 Jul; 56(7):1584-1592. PubMed ID: 33526918
[TBL] [Abstract] [Full Text] [Related]
9. [Clinical features and outcomes of cancer-related versus non-cancer-related sepsis in pediatric intensive care unit].
Zhou TL; Zhou YP; Zhang YC; Cui Y; Wang F; Chen RX; Rong QF; Wang CX
Zhonghua Er Ke Za Zhi; 2020 Jun; 58(6):482-487. PubMed ID: 32521960
[No Abstract] [Full Text] [Related]
10. [Clinical image identification of basal cell carcinoma and pigmented nevi based on convolutional neural network].
Xie B; He X; Huang W; Shen M; Li F; Zhao S
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2019 Sep; 44(9):1063-1070. PubMed ID: 31645498
[TBL] [Abstract] [Full Text] [Related]
11. [New molecular pathological strategies for malignant iris tumors].
Kakkassery V; Jünemann AM; Scheef BO; Grisanti S; Heindl LM
Ophthalmologe; 2019 Apr; 116(4):324-331. PubMed ID: 30623224
[TBL] [Abstract] [Full Text] [Related]
12. Current Status of Breast Reconstruction in Southern China: A 15 Year, Single Institutional Experience of 20,551 Breast cancer Patients.
Jia-Jian C; Nai-Si H; Jing-Yan X; Ben-Long Y; Guang-Yu L; Gen-Hong D; Zhi-Min S; Jiong W
Medicine (Baltimore); 2015 Aug; 94(34):e1399. PubMed ID: 26313786
[TBL] [Abstract] [Full Text] [Related]
13. Gefitinib for oesophageal cancer progressing after chemotherapy (COG): a phase 3, multicentre, double-blind, placebo-controlled randomised trial.
Dutton SJ; Ferry DR; Blazeby JM; Abbas H; Dahle-Smith A; Mansoor W; Thompson J; Harrison M; Chatterjee A; Falk S; Garcia-Alonso A; Fyfe DW; Hubner RA; Gamble T; Peachey L; Davoudianfar M; Pearson SR; Julier P; Jankowski J; Kerr R; Petty RD
Lancet Oncol; 2014 Jul; 15(8):894-904. PubMed ID: 24950987
[TBL] [Abstract] [Full Text] [Related]
14. Predicting survival outcome of localized melanoma: an electronic prediction tool based on the AJCC Melanoma Database.
Soong SJ; Ding S; Coit D; Balch CM; Gershenwald JE; Thompson JF; Gimotty P;
Ann Surg Oncol; 2010 Aug; 17(8):2006-14. PubMed ID: 20379784
[TBL] [Abstract] [Full Text] [Related]
15. Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial.
Clark LC; Dalkin B; Krongrad A; Combs GF; Turnbull BW; Slate EH; Witherington R; Herlong JH; Janosko E; Carpenter D; Borosso C; Falk S; Rounder J
Br J Urol; 1998 May; 81(5):730-4. PubMed ID: 9634050
[TBL] [Abstract] [Full Text] [Related]
16. [The humoral immunity indices of patients with malignant skin melanoma using the viral immunomodulator rigvir].
Glinkina LS; Heisele OG; Garklava RR; Muceniece AJ
Vopr Onkol; 1992; 38(5):534-40. PubMed ID: 1300751
[TBL] [Abstract] [Full Text] [Related]
